DE60007278D1 - Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung - Google Patents

Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung

Info

Publication number
DE60007278D1
DE60007278D1 DE60007278T DE60007278T DE60007278D1 DE 60007278 D1 DE60007278 D1 DE 60007278D1 DE 60007278 T DE60007278 T DE 60007278T DE 60007278 T DE60007278 T DE 60007278T DE 60007278 D1 DE60007278 D1 DE 60007278D1
Authority
DE
Germany
Prior art keywords
producing
medicine
fragments
hyaluronic acid
hematopoietic differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60007278T
Other languages
English (en)
Other versions
DE60007278T2 (de
Inventor
Florence Smadja-Joffe
Rachida-Sihem Charrad
Christine Chomienne
Bertrand Delpech
Claude Jasmin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE60007278D1 publication Critical patent/DE60007278D1/de
Application granted granted Critical
Publication of DE60007278T2 publication Critical patent/DE60007278T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • External Artificial Organs (AREA)
  • Basic Packing Technique (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DE60007278T 1999-02-11 2000-02-11 Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung Expired - Lifetime DE60007278T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9901644A FR2789587B1 (fr) 1999-02-11 1999-02-11 Moyens pour la regulation de la differenciation hematopoietique
FR9901644 1999-02-11
PCT/FR2000/000349 WO2000047163A2 (fr) 1999-02-11 2000-02-11 Utilisation de l'acide hyaluronique ou des fragments de celle-ci pour la regulation de la differenciation hematopoietique

Publications (2)

Publication Number Publication Date
DE60007278D1 true DE60007278D1 (de) 2004-01-29
DE60007278T2 DE60007278T2 (de) 2004-09-16

Family

ID=9541894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60007278T Expired - Lifetime DE60007278T2 (de) 1999-02-11 2000-02-11 Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung

Country Status (8)

Country Link
EP (1) EP1150692B1 (de)
AT (1) ATE256470T1 (de)
AU (1) AU2676200A (de)
CA (1) CA2362707A1 (de)
DE (1) DE60007278T2 (de)
ES (1) ES2212984T3 (de)
FR (1) FR2789587B1 (de)
WO (1) WO2000047163A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2167251B1 (es) * 2000-07-13 2003-09-16 Bioiberica Nuevos disacaridos con accion antiartrosica.
AUPR856501A0 (en) 2001-10-30 2001-11-29 Peter Maccallum Cancer Institute, The Detection of haematopoietic stem cells and progeny and uses thereof
EP2384759A1 (de) * 2010-05-06 2011-11-09 Suomen Punainen Risti Veripalvelu Sulfatierte Hyaluronsäure in Kombination mit G-CSF für den Einsatz bei der Mobilisierung von Blutstammzellen
US8546353B2 (en) 2010-05-06 2013-10-01 Glykos Finland Oy Compounds and combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240098A3 (de) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
ATE256137T1 (de) * 1994-12-01 2003-12-15 Seikagaku Kogyo Co Ltd Keratansulfatoligosaccharid-fraktion und sie enthaltendes medikament
DE19802540C1 (de) * 1998-01-23 1998-11-19 Univ Ludwigs Albert Verfahren zur Herstellung von dendritischen Zellen mit niedermolekularen Fragmenten der Hyaluronsäure

Also Published As

Publication number Publication date
FR2789587A1 (fr) 2000-08-18
EP1150692A2 (de) 2001-11-07
WO2000047163A2 (fr) 2000-08-17
CA2362707A1 (fr) 2000-08-17
WO2000047163A3 (fr) 2001-04-26
ES2212984T3 (es) 2004-08-16
DE60007278T2 (de) 2004-09-16
ATE256470T1 (de) 2004-01-15
EP1150692B1 (de) 2003-12-17
FR2789587B1 (fr) 2003-01-24
AU2676200A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
Dahiya et al. Hyaluronic acid: a boon in periodontal therapy
Evered et al. The biology of hyaluronan
Moseley et al. Hyaluronan and its potential role in periodontal healing
Maytin Hyaluronan: More than just a wrinkle filler
Morales Transforming growth factor-β1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures
DE60210752D1 (de) Pharmazeutische zusammensetzung enthaltend proteoglykan und ihre verwendung zur behandlung von entzündlichen erkrankungen
Hascall et al. 40. THE STRUCTURE OF CARTILAGE PROTEOGLYCANS
WO1999032516A3 (en) Pharmaceutical compositions containing the long pentraxin ptx3
BR9811923A (pt) Compostos possuindo atividade neuronal
Wu et al. Effects of exogenous glycosaminoglycans on human chondrocytes cultivated on type II collagen scaffolds
SE9704003L (sv) Formkroppar för användning som implantat i humanmedicin samt förfarande för framställning av sådana formkroppar
Flint et al. The glycosaminoglycans of Dupuytren's disease
DE60007278D1 (de) Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung
Truppe et al. Uptake of proteoglycans and sulfated glycosaminoglycans by cultured skin fibroblasts
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
Wiest et al. Native hyaluronic acid in dermatology–results of an expert meeting
Kolset Oversulfated chondroitin sulfate proteoglycan in cultured human peritoneal macrophages
Edward et al. Human melanoma cell‐derived factor (s) stimulate fibroblast glycosaminoglycan synthesis
Bartold et al. Isolation, identification, and quantitation of glycosaminoglycans synthesized by human gingival fibroblasts in vitro
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
Wasteson et al. Biosynthesis of chondroitin sulphate in cartilage regenerated from perichondrium
Torres et al. Nerve growth factor effect on adenosine transport in cultured chromaffin cells
Orlińska et al. Glycosaminoglycans–types, structure, functions, and the role in wound healing processes
Gümüş et al. Hyaluronic acid dermal filler promotes cartilage reshaping in rabbit ears
Lambe et al. Isolation, purification and characterization of hyaluronic acid: a concise review

Legal Events

Date Code Title Description
8364 No opposition during term of opposition